The world's first genetic test to assess the risk of individuals developing type 2 diabetes has been launched by Iceland's Decode Genetics Inc. <DCGN.O>.

Scientists leverage machine learning to decode gene regulation in the developing human brain ...

Dr. Michael C. Oldham's innovative gene coexpression analysis methods have transformed our understanding of brain cell diversity. His work spans from mapping cellular signatures in healthy ...

Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit.

News about deCODE Genetics, Incorporated, including commentary and archival articles published in The New York Times.

To further improve the effectiveness of these gene ferries, however, it is important to understand how these particles organize on a molecular level, encapsulate RNA, and release it again -- an ...

In 2012, deCode’s geneticists used the technique to study a tiny change in the APP gene and determined that the individuals who had it rarely developed Alzheimer’s. They otherwise seemed healthy.